Skip to main content
. 2022 May 24;36(3):325–336. doi: 10.1007/s40259-022-00531-z

Table 1.

Candidate dengue vaccines in phase I or phase II clinical trials

Candidate Platform Phase/stage References
TDEN-LAV (WRAIR/GSK) Live-attenuated Phase II (Discontinued) [9]
TDENV-PIV (WRAIR/FioCruz/GSK) Inactivated adjuvanted Phase I (No recent reports) [10]
D1ME100/TVDV (NMRC) DNA vaccine Phase I (No recent updates) [11]
V180 (DEN-80E) (Merck/NIAD) Recombinant (subunit) Phase I (Published 2019) [12]
DENV-1-LVHC Live-attenuated Phase I (Published 2021) Clinicaltrials.gov [13]